REQUEST A DEMO
Total
USD $0.00
Search more companies

October Pharma S.A.E. (Egypt)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: October Pharma S.A.E. Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

October Pharma is an Egyptian pharmaceutical producer, established in 1987 and based in the city of 6th of October. It manufactures medicines in various therapeutic classes, mainly for anti-infective, dermatological, gastrointestinal, urology, central nervous system, cardiovascular and vitamin therapy. The medicines are offered in various dosage forms, such as sterile and non-sterile semi-solids and liquids, tablets, capsules, gels and powder.

Headquarters
1St Industrial Zone, Plot 190
6th of October; Industrial Zone; Postal Code: 12566

Contact Details: Purchase the October Pharma S.A.E. report to view the information.

Website: http://www.octoberpharma.com

Basic Information
Total Employees:
Purchase the October Pharma S.A.E. report to view the information.
Outstanding Shares:
Purchase the October Pharma S.A.E. report to view the information.
Registered Capital:
Purchase the October Pharma S.A.E. report to view the information.
Financial Auditors:
Purchase the October Pharma S.A.E. report to view the information.
Incorporation Date:
1987
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
30.836%
Purchase this report to view the information.
28.704%
Purchase this report to view the information.
15.789%
Purchase this report to view the information.
13.158%
Company Performance
Financial values in the chart are available after October Pharma S.A.E. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
30.23%
Total operating revenue
30.12%
Operating profit (EBIT)
42.75%
EBITDA
43.94%
Net Profit (Loss) for the Period
20.09%
Total assets
29.23%
Total equity
33.32%
Operating Profit Margin (ROS)
2.81%
Net Profit Margin
-1.57%
Return on Equity (ROE)
-2.68%
Debt to Equity Ratio
-7.73%
Quick Ratio
0.32%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?